Related Experiment Videos
Effect of metyrapone on cortisol binding capacity in plasma
Acta Endocrinologica
|April 1, 1976
Summary
Metyrapone increases the ratio of free to total cortisol in plasma, both in vitro and in adrenalectomized patients. This finding may explain how metyrapone accelerates cortisol metabolism.
Area of Science:
- Biochemistry
- Endocrinology
- Pharmacology
Background:
- Cortisol is a key steroid hormone regulated by the hypothalamic-pituitary-adrenal axis.
- Metyrapone is an inhibitor of steroid 11β-hydroxylase, an enzyme critical for cortisol synthesis.
Purpose of the Study:
- To investigate the effect of metyrapone on the free:total cortisol ratio in plasma.
- To explore the potential mechanism by which metyrapone influences cortisol metabolism.
Main Methods:
- In vitro studies: Metyrapone (0.1 mg/ml) was added to normal plasma samples.
- In vivo studies: Metyrapone (30 mg/kg) was administered orally to adrenalectomized patients.
- Plasma cortisol levels (free and total) were measured before and after metyrapone administration.
Main Results:
- An increased ratio of free, non-protein-bound cortisol to total cortisol was observed in all six in vitro plasma samples.
- This increased free:total cortisol ratio was also demonstrated in 4 out of 5 adrenalectomized patients.
- The observed changes suggest a modulation of cortisol binding or metabolism.
Conclusions:
- Metyrapone administration leads to an elevated free:total cortisol ratio in plasma.
- This effect provides a potential explanation for the observed acceleration of cortisol metabolism by metyrapone.
- Further research is warranted to fully elucidate the pharmacokinetic and pharmacodynamic implications.